National Healthcare Properties
Valuation each multiple against its own 5-year range
Vs. peers REIT - Healthcare Facilities
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| National Healthcare Properties (NHP) | 1.08B | -45.18 | 1.18 | 0.51% |
| Welltower (WELL) | 176.32B | 104.95 | 3.63 | 1.28% |
| American Healthcare REIT (AHR) | 13.35B | 117.43 | 2.41 | 1.74% |
| Healthpeak Properties (DOC) | 13.27B | 35.63 | 1.69 | 6.34% |
| Medical Properties Trust (MPT) | 1.03B | 4.17 | 0.22 | 20.57% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 8.0% below Morningstar's fair value estimate.
Fair value
National Healthcare Properties Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% discount to our quantitative fair value estimate of $16.00 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The company's valuation metrics strengthen our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 94.9%, which lies in the top 40% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.
The company's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 1.4, a core component of leverage, ranks in the bottom 20% globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.
National Healthcare Properties discussion 0 comments